IRIS
LAI, PIERO LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.871
Totale 6.871
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 6.871
Totale 6.871
Salva come PNG Salva come JPEG
Città #
Genova 5.020
Rapallo 941
Genoa 708
Vado Ligure 175
Bordighera 27
Totale 6.871
Salva come PNG Salva come JPEG
Nome #
Epidemiology of tick-borne encephalitis (TBE) in Europe and its prevention by available vaccines 152
Age-related differences in the accuracy of web query-based predictions of influenza-like illness 145
A new assay for hepatitis C virus (HCV) core antigen detection: an alternative to nucleic acid technologies in positive or indeterminate anti-HCV subjects? 143
Do the omeprazole family compounds exert a protective effect against influenza-like illness? 139
Clinical and socioeconomic impact of seasonal and pandemic influenza in adults and the elderly 136
Safety and tolerability of bivalent HPV vaccine: an Italian post-licensure study 135
Molecular characterization of a new variant of rotavirus P[8]G9 predominant in a sentinel-based survey in central Italy 129
An overview on the implementation of HPV vaccination in Europe 128
Cost-benefit evaluation of influenza vaccination in the elderly in the Italian region of Liguria 126
Burden of the 1999-2008 seasonal influenza epidemics in Italy: comparison with the H1N1v (A/California/07/09) pandemic. 123
Cause of death among people with AIDS in Liguria (Italy). A different pattern for intravenous drug users? 121
Influenza vaccination: from epidemiological aspects and advances in research to dissent and vaccination policies 121
Sexual behaviour and risk factors for the acquisition of human papillomavirus infections in young people in Italy: suggestions for future vaccination policies 119
Neisseria meningitidis B vaccines 118
A comprehensive analysis of Italian web pages mentioning squalene-based influenza vaccine adjuvants reveals a high prevalence of misinformation 118
Prevalence of human papillomavirus in young Italian women with normal cytology: how should we adapt the national vaccination policy? 117
Long-term decline of (137)Cs concentration in honey in the second decade after the Chernobyl accident 113
An overview of current and potential use of information and communication technologies for immunization promotion among adolescents 111
Effectiveness of a 23-valent polysaccharide vaccine in preventing pneumonia and non-invasive pneumococcal infection in elderly people: a large-scale retrospective cohort study 107
Appropriateness and preferential use of different seasonal influenza vaccines: A pilot study on the opinion of vaccinating physicians in Italy 107
Neisseria meningitidis B vaccines: recent advances and possible immunization policies. 106
Chlamydia trachomatis prevalence and chlamydial/ HPV co-infection among HPV-unvaccinated young Italian females with normal cytology 102
Effectiveness of adjuvanted seasonal influenza vaccines (Inflexal V® and Fluad®) in preventing hospitalization for influenza and pneumonia in the elderly. A matched case-control study 99
Influenza Burden on Italian Paediatric Population: Five year Nation-wide Surveillance and Correlation between Epidemiological and Virological Data 98
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: Need to improve vaccination coverage 92
Benefit-cost evaluation of Influenza vaccination in the elderly in the Italian Region of Liguria 90
Influenza epidemiology in Italy two years after the 2009-2010 pandemic: Need to improve vaccination coverage. 89
Valutazione della tollerabilità del vaccino anti-HPV nelle donne liguri 88
Development of a sensitive real-time PCR for simultaneous detection and subtyping of influenza A and B viruses 83
How the knowledge of interactions between meningococcus and the human immune system has been used to prepare effective Neisseria meningitidis vaccines 83
Utility of thymosin alpha-1 (Zadaxin) as a co-adjuvant in influenza vaccines: a review 82
Virological investigation on aerosol from waste depuration plants 81
Relevance of air condititioning for 222Radon concentration in commercial concerns of the Savona Province, Italy 81
Anamnestic response to administration of purified non-adsorbent hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titres. 81
Heterogeneous estimates of influenza virus types A and B in the elderly: Results of a meta-regression analysis 81
Weekly monitoring of Influenza Like Illness (ILI) and other acute respiratory infections (ARI) impact on pediatric population during the last two years in 10 Italian Regions. 80
NEW VERSUS OLD MENINGOCOCCAL GROUP B VACCINES: HOW THE NEW ONES MAY BENEFIT INFANTS & TODDLERS 80
People living with undiagnosed HIV infection and a low CD4 count: Estimates from surveillance data, Italy, 2012 to 2014 80
Burden of rotavirus associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance 80
Prevalence of the Human Papillomavirus genotypes in Italian women undergoing voluntary cervical cancer screening: Evaluation of cumulative incidence from 16 to 26 years of age and evaluationof the effect of extending Italian vaccination policy with bivalent vaccine. 79
VIROLOGICAL SURVEILLANCE AS A TOOL FOR ASSESSING HUMAN PAPILLOMAVIRUS VACCINATION 79
La vaccinazione universale dei bambini contro l’influenza con il vaccino Vaxigrip Tetra® in Italia: risultati di una valutazione di Health Technology Assessment (HTA) [The universal influenza vaccination in children with Vaxigrip Tetra® in Italy: an evaluation of Health Technology Assessment] 79
Utility of virosomal adjuvated influenza vaccines - a review of the literature. 78
Relevance of main factor affecting Radon concentration in multi-storey buildings in Liguria (Northern Italy) 75
Benefit-cost evaluation of Influenza vaccination in elderly people in Liguria, Italy 73
Aflunov: a prepandemic influenza vaccine 73
Health Technology Assessment (HTA) of the introduction of influenza vaccination for Italian children with Fluenz Tetra® 73
Influenza surveillance by general practitioners and paediatricians in the Italian region of Liguria in 1999-2002 72
Neisseria meningitidis: pathogenetic mechanisms to overcome the human immune defences 71
Why the anti-meningococcal b vaccination during adolescence should be implemented in italy: An overview of available evidence 71
Tubercolosis today: populations at risk 71
Live attenuated influenza vaccine-a review 69
PREVALENZA DEI TIPI DI HPV NELLE DONNE ITALIANE (16-26 ANNI) SOTTOPOSTE A SCREENING VOLONTARIO DEL CANCRO CERVICALE. VALUTAZIONE DELL’INCIDENZA CUMULATIVA E DELLA POSSIBILE ESTENSIONE DELLA VACCINAZIONE CON IL VACCINO BIVALENTE. 69
Overview of Japanese encephalitis disease and its prevention. Focus on IC51 vaccine (IXIARO®) 69
A pharmacoeconomic appraisal of the strategy to tackle the H1N1v (A/California/07/09) pandemic in Italy: relevance of the CIRI-IV surveillance system. 68
Valutazione costi-benefici della vaccinazione influenzale in Liguria 66
Assessment and prevention of radioactive risk due to 222Radon in commercial concerns of Genoa 66
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part I: influenza life-cycle and currently available drugs 66
Vaccination promotion within a framework of public health education 64
Hepatitis B immunization and anti-HBs quantitation: comparative performance of thirteen commercial immunoassays 64
Influenza vaccination in italian healthcare workers (2018–2019 season): Strengths and weaknesses. results of a cohort study in two large italian hospitals 63
Diminuzione delle coperture vaccinali per influenza: riflessi sull'epidemiologia stagionale 2012-13 in Liguria. 62
In-depth phylogenetic analysis of the hemagglutinin gene of influenza A(H3N2) viruses circulating during the 2016-2017 season revealed egg-adaptive mutations of vaccine strains 62
Tobacco smoking among students in an urban area in Northern Italy 58
Le vaccinazioni dell'adulto a rischio e dell'anziano 57
Valutazione costi/benefici della vaccinazione influenzale negli anziani in Liguria (Italia) 57
Burden dell’influenza nella popolazione italiana nel periodo compreso tra il 1999 e il 2004: correlazioni tra sorveglianza clinico-epidemiologica e caratterizzazione antigenica e molecolare dei virus influenzali 53
Vaccinations for adults at risk and the elderly 51
EPIDEMIOLOGIA DELL’INFLUENZA IN ITALIA DOPO LA PANDEMIA 2009-10. NECESSITÀ DI MIGLIORARE LE COPERTURE VACCINALI. 51
Today's influenza vaccines. Why an adjuvant is needed and How it works 51
Health Technology Assessment e vaccinazioni in Italia 50
Efficacia dei vaccini adiuvati e ricadute farmaco-economiche 49
Influenza vaccination of elderly: relaunch time 49
The urban myth of the association between neurological disorders and vaccinations. 48
HTA in vaccine prevention: application to vaccinations against invasive diseases. 44
Meningococcal B vaccination strategies and their practical application in Italy 44
Health Technology Assessment (HTA) of the introduction of additional cohorts for anti-meningococcal vaccination with quadrivalent conjugate vaccines in Italy 42
Influenza surveillance in the Italian region of Liguria in the winter of 1999-2000 by general practitioners and paediatricians: socio-economic implications 41
Influenza vaccination coverage in Italy in 1999-2013: impact on incidence of ILIs in the elderly. 41
Valutazione dell'impatto epidemiologico, sanitario ed aconomico della malattia da herpes zoster in Italia 38
UTILIZZO DELL'HTA IN PREVENZIONE VACCINALE: APPLICAZIONE ALLE VACCINAZIONI CONTRO LE MALATTIE INVASIVE 37
Burden of typhoid fever and cholera: Similarities and differences. Prevention strategies for European travelers to endemic/epidemic areas 37
Health Technology Assessment of meningococcal B vaccine (Trumenba®) in adolescent in Italy 36
Valutazione della copertura antinfluenzale in Liguria mediante somministrazione di questionario telefonico 34
Prevalenza dell’anti-HCV in pazienti plurioperati 29
Demographic and Socio-economic Determinants of Poor HIV-risk Perception at First HIV Diagnosis: Analysis of the HIV Surveillance Data, Italy 2010-2016 29
Implementazione dei tassi di copertura vaccinale antinfluenzale nel personale sanitario dell'A.U.O. San Martino di Genova durante la stagione 2005-06 27
Enhanced Passive Safety Surveillance (EPSS) confirms an optimal safety profile of the use of MF59®-adjuvanted influenza vaccine in older adults: Results from three consecutive seasons 25
No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020 23
[Health Technology Assessment: a value-based tool for the evaluation of healthcare technologies. Reassessment of the cell-culture-derived quadrivalent influenza vaccine: Flucelvax Tetra® 2.0] 20
The New Quadrivalent Adjuvanted Influenza Vaccine for the Italian Elderly: A Health Technology Assessment 12
Enhanced passive safety surveillance of the MF59-adjuvanted quadrivalent influenza vaccine in the elderly during the 2021/22 influenza season 6
Three seasons of enhanced safety surveillance of a cell culture-based quadrivalent influenza vaccine 5
Totale 6.990
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.162
article - articoli 18.628
book - libri 0
conference - conferenze 3.290
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 244
Totale 44.324
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.669 0 0 78 68 138 195 256 103 173 359 210 89
2020/2021406 24 22 32 25 53 40 22 26 39 41 43 39
2021/2022988 21 97 74 96 48 45 55 249 62 77 41 123
2022/20231.125 108 81 16 105 172 208 4 76 172 6 164 13
2023/2024537 18 84 12 75 34 92 34 55 40 7 34 52
2024/2025205 54 132 19 0 0 0 0 0 0 0 0 0
Totale 6.990